Skip to product information
1 of 5

RIGVIR SE - Biologically Active Food Supplement

RIGVIR SE - Biologically Active Food Supplement

Regular price $ 3,000.00 MXN
Regular price Sale price $ 3,000.00 MXN
Sale Sold out
Shipping calculated at checkout.
Effective way to enrich the diet and make the body more resistant to today's greatest health challenge.
The development is based on decades of scientific and clinical trials.
Approved after completing all necessary tests and studies.
Third party tested.
Take only once a month.
View full details

Suggested consumption method

Consume in the morning on an empty stomach with a glass of water.

To prevent cancer and stimulate the immune system: 1 capsule per month.

In case of suspected cancer or precancerous clinical signs are observed, including increased tumor markers: 2-4 capsules per month at equal intervals between doses.

In case of weakened immune system: 2-4 capsules per month.

If cancer has been diagnosed, the use of Rigvir SE should be based on the recommendations of professionals.

In any case, it is not recommended to exceed the quantity of 6 capsules per month.

When used between sessions of toxic therapy: the supplement should be taken at least 5 days before/after the planned therapy.

In case of intensive use of Rigvir SE, it is recommended to observe the dynamics of immunological parameters .

rigvir méxico

Important information to consider before purchasing:

Storage and Shipping

Keep refrigerated (+4°C).

The product can be transported at temperatures of up to +20°C for up to 5 days.

IMPORTANT: Please be available at the delivery address to minimize the time the product spends without refrigeration. Inadequate storage conditions will cause product degradation.

The shipping cost is $570 MXN to any state in Mexico. The estimated delivery time is 24 hours via express shipping from the processing of your purchase.

Characteristics

Serving Size: 1 capsule


Servings per Container: 1 capsule in a moisture-resistant packet


Ingredients per capsule:
Whey protein isolate: 190 mg
Trace amounts of non-genetically modified and non-pathogenic lyophilized ECHO-7 virus Rigvir: 10 mg
Vitamin B2 (riboflavin): 5 mg


Other ingredients: Hydroxypropyl methylcellulose (capsule coating). This product contains milk; it does not contain gluten, wheat, yeast, or soy.


Warning: Food supplements should not be used as a substitute for a varied and balanced diet. Pregnant and breastfeeding women, as well as children, should not use this supplement. This product is not intended to diagnose, treat, cure, or prevent any disease.

Do not use if the sachet material is pierced or missing.


Produced: GMP facility in the EU. Tested by an external laboratory. Internationally patented.

Additional Information

Package Size: 95x70x25 mm.


Expiration Date: 12 months.

The expiration date will be taken into account when processing the order.

Return Conditions

If damages to the internal packaging of Rigvir SE are discovered upon receipt, the product will be replaced or payment refunded within 14 days of receiving the product.

History

NO NAUSEA, NO HAIR LOSS, NO SIDE EFFECTS, NO HEPATIC AND RENAL TOXICITY, NO COLLAPSE OF YOUR IMMUNE SYSTEM.

Rigvir is a revolutionary approach to cancer treatment and fits perfectly with our approach to health and wellness as it has virtually no side effects. Rigvir oncolytic virotherapy is like a guided missile aimed solely at cancer cells. Rigvir oncolytic virotherapy uses the oncolytic power of the ECHO-7 virus to target and destroy malignant tumors. This virus only multiplies in tumors to destroy them and not in healthy tissue. Rigvir is a live attenuated virus, non-pathogenic, not genetically modified, and is a healing therapeutic virus discovered by Professor Aina Mucienece, an immunologist from Latvia and founder of Rigvir therapy, who discovered that the ECHO-7 virus was effective for melanoma treatment. Dr. Aina Mucienece worked at the Pauls Stradins University Clinical Hospital and the National Oncology Center as an immunology consultant from 1977 to 2003. In 2002, she was appointed an honorary member of the Latvian Society of Oncologists. In 2005, Dr. Muceniece received the Cross of Recognition for merit in the service of her country, Latvia. Before her death in 2010, she published 190 articles on immunology and cancer.